RedHill Biopharma reported $25.34M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Cara Therapeutics USD 32.07M 6.95M Dec/2025
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 156.57M 58.73M Dec/2025
Cronos Group USD 1.17B 25.03M Mar/2026
RedHill Biopharma USD 25.34M 6.97M Dec/2025